Mederi Therapeutics Inc. (Mederi Therapeutics), has launched its Secca system for treatment of bowel incontinence in US. Secca Therapy is a minimally invasive procedure for bowel incontinence. In the therapy radiofrequency (RF) energy is delivered to tighten the muscles of the anal canal, producing better bowel control and reducing the symptoms of incontinence.

This innovative treatment bridges the gap between often unsuccessful conservative measures, such as diet modification and biofeedback, and expensive and disfiguring surgical treatment, said Mederi CEO, Will Rutan. The effect of bowel incontinence on quality of life is devastating, so the positive response to the release of the Secca system is not surprising.

Secca therapy is an outpatient procedure that takes approximately 45 minutes and is performed in an endoscopy suite or ambulatory surgery unit, with the patient under general anesthesia or conscious sedation. Patients go home approximately one to two hours after the procedure and, typically, resume normal activities within several days. In clinical trials as many as 8 out of 10 patients had a positive clinical response to Secca therapy and showed significant improvement in quality of life scores. Further, recent clinical studies have shown symptom relief lasting as long as five years.